16. Wilke, T.; Schneider, M.; Kleinermanns, K. Open J. Phys. Chem.
2013, 3, 97.
17. Thomas, D. J.; Sadler, A.; Subrahmanyam, V.V.; Siegel, D.;
Reasor, M.J.; Wierda, D.; Ross, D. Mol. Pharmacol. 1990, 37,
255.
18. Li, Y.; Trush, M.A. Arch Biochem. Biophys. 1993, 300, 346.
19. Luo, L.; Jiang, L.; Geng, C.; Cao, J.; Zhong, L. Chem. Biol.
Interact. 2008, 173, 1.
Melanocyte stimulating hormones (MSHs) play a key role in
producing coloured pigmentation found in the skin, hair and eyes.
-Melanocyte stimulating hormone (α-MSH), an endogenous
tridecapeptide hormone produced by melanocortin is the most
important one of the MSHs in stimulating melanogenesis. All
groups were exposed with 1 during 9 ~ 35 hpf and then treated
with mock (group I), 1 (group II), α-MSH (group III), and 1 + α-
MSH co-treatment (group IV) (Fig. 6). The removal of 1 (group
I) recovered the pigmentation (low BT, HB & moderate SB). As
expected, the treatment of 1 (group II) suppressed the
pigmentation (high BT, HB & low SB) and the treatment of α-
MSH (group III) stimulated the pigmentation (low BT, HB &
high SB). Interestingly, the co-treatment of 1 and α-MSH (group
IV) showed the similar pattern with group II; a suppressed
pigmentation (high BT, HB & low SB). These data indicate that
Supplementary Material
Supplementary data associated with this article (synthesis and
characterization of 1 and 2, experiment details of stability test,
logP measurement, MTT assay, phenotype-based evaluation of
zebrafish melanogenesis) can be found, in the online version, at
1
acts as
a competitive inhibitor of -MSH induced
melanogenesis.
In summary, we synthesized two hydroquinone-tetraethylene
glycol conjugates, 1 and 2. The logP, photophysical stability, and
redox chemical stability of them were compared with HQ. The
mono tetraethylene glycol-functionalization of HQ improved the
photophysical and Cu2+ redox chemical stability. MTT assay in
HF-16 cells showed 1 is less cytotoxic than HQ or 2. We
observed the regulatory effect of 1 and 2 on zebrafish
pigmentation. The quantitative image analysis of zebrafish larvae
showed that 1 and 2 suppressed the pigmentation of zebrafish in
a dose-dependent manner. The comparative experiments on
stability, cytotoxicity, and zebrafish pigmentation between HQ,
1, and 2 suggest that mono tetraethylene glycol-functionalization
of HQ is an alternative solution to overcome the conventional
disadvantages of HQ.
Acknowledgments
This work was supported by a grant from the Kyung Hee
University in 2011 (KHU-20110478).
References and notes
1.
2.
3.
4.
Halder, R. M.; Richards, G. M. Skin Therapy Lett. 2004, 9, 1.
Katsambas, A. D.; Stratigos, A. J. Clin. Dermatol. 2001, 19, 483.
Bruce, S. J Drugs Dermatol. 2013, 12, 27.
FDA (1982). Skin bleaching drug products for over-the-counter
human use; tentative final monograph. Federal Register 47:39108.
Sundvik, M.; Panula, P. In Animal Models of Movement
Disorders; Lane, E. M.; Dunnett, S. B., Eds.; Springer: Humana,
2012; Vol. 61, Chapter 2, pp 11-30.
5.
6.
Pichler, F. B.; Laurenson, S.; Williams, L. C.; Dodd, A.; Copp, B.
R.; Love, D. R. Nat. Biotechnol. 2003, 21, 879.
7.
8.
Langheinrich, U. Bioessays, 2003, 25, 904.
Choi, T. Y.; Kim, J. H.; Ko, D. H.; Kim, C. H.; Hwang, J. S.; Ahn,
S.; Kim, S. Y.; Kim, C. D.; Lee, J. H.; Yoon, T. J. Pigment Cell
Res. 2007, 20, 120.
9.
Kang, J. S.; DeLuca, P. P.; Lee, K. C. Exp. Opin. Emerg. Drugs
2009, 14, 363.
10. Sahner, D.; Paaschen, H.; Marcantonio, A.; Eldon, M. J. Pain
2008, 9, 28.
11. Bentley, M. D.; Viegas, T. X.; Goodin, R. R.; Cheng, L.; Zhao, X.
U.S. Patent 7,786,133, 2010.
12. Ekwuribe, N. N.; Odenbaugh, A. L. U.S. Patent WO2005016240,
2005.
13. Kim, D. H.; Hong, B. N.; Le, H. T.; Hong, H. N.; Lim, C. W.;
Park, K. H.; Kim, T. W.; Kang, D. H. Bioorg. Med. Chem. Lett.
2012, 22, 4609.
14. All melting points, except NCAP, were cited from ChemIDplus
TOXNET, National Library of Medicine, NIH.
15. Stella, V. J.; Amidon, G. L.; Connors, K. A. Chemical Stability of
Pharmaceuticals: A Handbook for Pharmacists; 2nd edit.; John
Wiley & Sons, Inc., 1986, Chapter 4, pp.90-92.